Navigation Links
Acrongenomics Acquires Equity Stake in Molecular Vision
Date:2/4/2008

GENEVA, February 4 /PRNewswire-FirstCall/ -- Acrongenomics, Inc. (OTC: AGNM) is pleased to announce that they have acquired a 10.9% interest in Molecular Vision Limited, on a fully diluted basis. The cash consideration will be used by Molecular Vision for working capital and to further develop its technology.

Molecular Vision is developing low cost easy-to-use credit-card sized devices for medical testing that will greatly extend the in-house tools available to the general practitioner. The devices are being developed to allow near patient quantitative diagnosis, currently focusing on key areas of high disease burden, namely kidney function and cardiovascular disease. The technology also has additional applications outside the diagnostics market (e.g. forensic science, homeland security and environmental monitoring).

About Acrongenomics Inc.

Acrongenomics Inc. is a publicly traded company that focuses on investing in and commercializing novel technology platforms concerning the Life Sciences sector. Acrongenomics brings novel and realistic concepts to market by transforming scientific innovations into tangible, consumer-orientated applications. The company has its headquarters in Geneva, Switzerland.

About Molecular Vision Limited

Molecular Vision Limited is a spin-out company of Imperial college, London UK. The company was founded by three Imperial College London researchers - Prof. Donal Bradley, Prof. Andrew De Mello and Dr. John De Mello - in 2002 in order to meet a clearly defined demand in the medical diagnostics, biosensors and analytical instrumentations markets and the need for miniaturized chemical and biological detectors offering high sensitivity and functionality at low cost. The company has directly addressed this market demand by inventing a novel method for optical detection based on recent advances in organic electronics and light emitting diodes combined with microfluidics technology. The company has mainly
'/>"/>

SOURCE Acrongenomics Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
2. Neogen Acquires Kane Enterprises
3. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
4. Thermo Fisher Scientific Acquires Instrument Sales Business of Davis Inotek
5. United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider
6. NSF International Acquires David Begg Associates
7. United BioSource Acquires Caro Research, Leader in Simulation Modeling
8. Respironics Acquires Apollo Light Systems, Inc., Expands into Circadian Rhythm Device-Based Therapy Market
9. Thermo Fisher Scientific Acquires Logistics Provider to Strengthen Clinical Trials Management Services
10. Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery
11. Thermo Fisher Scientific Acquires Leader in Micro-Volume Spectrophotometers, NanoDrop Technologies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24 ...asdaq: DCGN ) today announced that it has received...in the company,s common stock will be,suspended as...led with the,Securities and Exchange Commission, w...g on Nasdaq, unless the company files an appeal to...
(Date:11/24/2009)..., SAN MATEO, Calif., Nov. 24 /PRNewswire-FirstC...rmaceutical company focused on developing and comm...nced today that Anthony DiTonno, President and Chi...he 21st Annual Piper Jaffray Health Care Conferenc...alace Hotel in New York, New York. ,, Mr. DiTo...
(Date:11/24/2009)..., TSX VENTURE: HTL , TORONTO, Nov. 24 /PRNews...), formerly Calotto Capital Inc., a leading provid...he stem cell research and fertility clinic markets... for the third quarter ended September 30, 2009. ,...46 million compared with $1.43 million in Q3 2008,...
(Date:11/24/2009)... Program Connects Customers with Par...lected with DNA Genotek Products , ... DNA Genotek , a leading provider of products for ...eparation, today announced its new global partner ...ts for DNA Genotek,s partner community and is desi...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...t. 15 Symmetry Medical Inc.,(NYSE: SMA ), a lead...,orthopedic device industry and other medical mark...t and Chief Executive Officer, is scheduled to,pre... The Grand Hyatt New,York in New York City on Thur...e Web cast of the presentation will be available o...
... Sept. 15 Assay Designs and the Spinal,Muscular A...nce a,collaborative agreement for development of r... protein to expedite drug discovery and developmen...eading genetic cause of,mortality in infants and t...ve been selected by the SMA Foundation, and to hel...
...5 Enobia Pharma, an emerging biotech,company focu...one,disorders, presented pre-clinical data demonst...or hypophosphatasia appears to heal bones that,hav...arlier pre-clinical,data showed that ERT with Enob...vival and prevents bone hypomineralization associa...
Other Biology Technology:Symmetry Medical to Present at UBS Global Life Sciences Conference 2Assay Designs(TM), Inc. and the Spinal Muscular Atrophy Foundation Announce Collaboration To Accelerate the Discovery of New Therapeutics for Spinal Muscular Atrophy (SMA) 2Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice 2Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice 3
(Date:11/24/2009)...a matter of debate. A high-profile study a few yea...f their carbon from trees and leaves, evidence for...atic ecosystems. , But new research from the Uni...be true. Algae provide a much richer diet for fish...lished this week in the Proceedings of the Nation...
(Date:11/23/2009)...23, 2009 Applied mathematicians dissected the mor... a characteristic long leaf with a saddle-like arc...dges. The simple cause of the lily,s fan-like shap...differential growthwas revealed by using an equall...aiyi Liang, a postdoctoral student at Harvard,s Sc...
(Date:11/23/2009)...provides "incontrovertible evidence" that the volc...ra about 73,000 years ago deforested much of centr...earchers report. , The volcano ejected an estima...e, leaving a crater (now the world,s largest volca...eters wide. Ash from the event has been found in I...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3The cause behind the characteristic shape of a long leaf revealed 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review 49849 1Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review 49849 2Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review 49849 3Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review 49849 4New theraplex SA FACIAL PEEL Shows True Colors at Cosmetic Boot Camp 49847 1New theraplex SA FACIAL PEEL Shows True Colors at Cosmetic Boot Camp 49847 2Micro Businesses Offer Strong Opinions On Health Reform Proposals 49845 1Micro Businesses Offer Strong Opinions On Health Reform Proposals 49845 2Micro Businesses Offer Strong Opinions On Health Reform Proposals 49845 3Micro Businesses Offer Strong Opinions On Health Reform Proposals 49845 4
...st clinical evidence that gene therapy reduces sym...portant milestone for this promising treatment whi...ed in the February issue of the journal Human Gen...atients with severe rheumatoid arthritis conducted...ael Deaconess Medical Center (BIDMC). , Original...
...globe, the demand for water is increasing with the...reas are requiring more water for drinking, sanita...n water supplies. In addition, depleting ground wa...hange have led to an increased importance for the ...ent water pollution, and efficiently allocate wate...
...thousands of lives a year, University of Utah Scho... vessel disorder leading to unpredictable, sometim... or other problems is treatable with the same stat...igh cholesterol. , If the results of a study in m...atins could provide a safe, inexpensive treatment ...
Other Biology News:Gene therapy demonstrates benefit in patients with rheumatoid arthritis 2Gene therapy demonstrates benefit in patients with rheumatoid arthritis 3How to move agriculture forward with limited water 2Statins may treat blood vessel disorder that can lead to fatal strokes 2Statins may treat blood vessel disorder that can lead to fatal strokes 3
...s constitute the principal excitatory neurotransmi...receptors exist: Ionotropic receptors, and metabot...e oligomeric complexes of various subunits (GluR1-...cium channels. Metabotropic glutamate receptors ar...
PIP Beads di-C6 PtdIns(4,5)P2 from Echelon Biosciences Inc.
Mouse Anti-D-Dimer Antibody, Unconjugated from HyTest Ltd.
...ogen corresponds to amino acids 2-105 from human S...has been successfully used in Western blot, immuno... By Western blot, this antibody detects an ~ 60 kD...s also been used in immunoprecipitation and immuno...
Biology Products: